HMUS:LSE:LSE-HSBC MSCI USA UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 4550

Change

-14.50 (-0.32)%

Market Cap

N/A

Volume

718.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.38 (+0.14%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.41 (+0.28%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.39%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.05 (+0.30%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.48%)

USD 266.08B
0QZO:LSE 0QZO

+8.80 (+8.82%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.08 (+0.26%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

+2.23 (+1.38%)

USD 202.26B

ETFs Containing HMUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.03% 88% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.03% 88% B+ 82% B
Trailing 12 Months  
Capital Gain 30.56% 84% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.56% 84% B 78% C+
Trailing 5 Years  
Capital Gain 98.15% 92% A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 98.15% 92% A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 14.12% 77% C+ 77% C+
Dividend Return 14.13% 77% C+ 77% C+
Total Return 0.01% 18% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 12.08% 58% F 74% C
Risk Adjusted Return 116.96% 98% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.